When you receive your test in the mail, collect a blood sample (just a finger prick!) and mail it to Hones CLIA and CAP-accredited lab partner
Peptide therapy is typically one part of a broader plan that includes diet, targeted supplementation, and addressing root causes identified through testing like the GI-MAP
BPC-157 came off the FDA Category 2 list effective April 23, 2026, and is one of the seven peptides under PCAC review for 503A compounding eligibility in July 2026
We have a robust product portfolio comprising of Medicines spread over major therapeutic areas particularly Antibacterial, Antimalarial, Antiviral, Antifungal,Antitubercular, Erectile dysfunction, Antidepressants, Antipsychotic, NSAID, Painkiller , Analgesic, Anesthetic, Antiallergic, Antidiabetic, Antiemetic, Antiasthmatic, Antacid, Antibiotic, Cardiovascular, Antihypertensive, Dermatological and many more